New hope for kidney cancer patients who Can't have surgery: targeted radiation trial launches

NCT ID NCT05023265

Recruiting now Disease control Sponsor: Sunnybrook Health Sciences Centre Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a precise type of radiation, called SBRT, for people with kidney cancer that cannot be removed with surgery. The treatment aims to control the tumor while limiting damage to healthy tissue. Researchers will track tumor control and quality of life in 70 participants over two years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: stereotactic body radiotherapy (SBRT)
What this could lead to: If successful, this could offer a non-invasive treatment option for people with kidney cancer who cannot have surgery, potentially controlling the tumor while preserving quality of life.
What could go wrong: This is a small, early-phase study (70 participants) without a comparison group, so results may not apply broadly. Side effects from radiation, though minimized, are still possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

renal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RENAL CELL CARCINOMA

Contacts and locations

Locations

Sunnybrook Health Sciences
RECRUITING

Toronto, Ontario, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.